Promacta 25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4G0Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,949
Award facts
- Contract value 100% obligated
- $45,948.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 28, 2026, the Defense Logistics Agency awarded a $45,948.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets in quantities of 30 units. The contract is non-competitive and carries an ultimate completion date of February 19, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The awardee operates as a subsidiary of parent company Cencora, Inc., which does business as AmerisourceBergen.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract structure and vendor capability align with the Defense Logistics Agency's mission to supply critical pharmaceuticals to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4G0Q?
SPE2DR26F4G0Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4G0Q worth?
The government has obligated $45,949 on SPE2DR26F4G0Q.
Is contract SPE2DR26F4G0Q an order under another contract?
Yes. SPE2DR26F4G0Q is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4G0Q competed?
The extent of competition for SPE2DR26F4G0Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award